Eslicarbazepine acetate as a therapeutic option in a patient with carbamazepine-induced rash and HLA-A*31:01. [electronic resource]
Producer: 20170417Description: 81-82 p. digitalISSN:- 1532-2688
- Adult
- Anticonvulsants -- adverse effects
- Carbamazepine -- adverse effects
- Dibenzazepines -- therapeutic use
- Epilepsy, Frontal Lobe -- drug therapy
- Exanthema -- etiology
- Female
- HLA-B15 Antigen -- genetics
- Haplotypes
- Humans
- Pharmacogenomic Variants
- Voltage-Gated Sodium Channel Blockers -- therapeutic use
No physical items for this record
Publication Type: Case Reports; Journal Article
There are no comments on this title.
Log in to your account to post a comment.